Search Results - "atherothrombosis"
-
1
THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS
Published 2016-01-01Subjects: “…atherothrombosis…”Current issues of atherothrombosis prevention and treatment optimization with antiplatelet therapy in patients with cardioascular diseases are discussed. Role of clopidogrel in contemporary antiplatelet therapy is focused on, especially in the aspect of the problem of aspirin resistance. Chronology...
Get full text
Article -
2
ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS
Published 2015-12-01Subjects: Get full textThe results of large-scale clinical trials have convincingly demonstrated the effectiveness of acetylsalicylic acid (ASA) in primary and secondary prevention of atherothrombotic events. Studies on the safety of different ASA formulations have been continuing. Magnesium hydroxide included in combined...
Article -
3
ПОСЛЕДНЯЯ БОЛЕЗНЬ ЛЮДОВИКА XIV
Published 2014-12-01Subjects: Get full textOn the basis of historical documents, memoirs of contemporaries, the authors analyze the clinic and development of atherothrombosis the left femoral artery complicated by gangrene of the limb from which sufferd the well-known historical figures — the king of France Louis XIV. The authors clarify the...
Article -
4
Factors determining homocysteine levels in Russian patients with stable coronary heart disease
Published 2010-08-01Subjects: Get full textAim. To identify the factors determining homocysteine (HMC) levels in Russian patients with stable coronary heart disease (CHD). Material and methods. The study included 506 patients (388 men; mean age 59,4±12,2 years) with stable CHD. Classical risk factors (RFs) of cardiovascular disease (CVD), re...
Article -
5
Comparative study of specific activity of rectal suppositories with clopidogrel
Published 2021-12-01Subjects: “…atherothrombosis…”One of the most effective platelet antiaggregants is clopidogrel, inhibiting platelet activation by selectively binding adenosine diphosphate (ADP) with specific receptors. However, in a number of clinical situations it is necessary to have a pronounced antithrombotic effect in the shortest possible...
Get full text
Article -
6
Factors influencing cardiovascular mortality in Russian population
Published 2005-02-01Subjects: Get full textAccording to the results of prospective studies performed at the State Research Center for Preventive Medicine, the data on main cardiovascular risk factors prevalence, their role in total cardiovascular mortality, coronary heart disease and stroke mortality in Russian population are presented. It i...
Article -
7
ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE
Published 2010-08-01Subjects: “…atherothrombosis…”This review is focused on the main aspects of aspirin therapy in the prevention of various atherothrombosis manifestations and coronary heart disease (CVD). The major mechanism of aspirin action is explained, and additional aspirin benefits, unrelated to its anti-aggregant activity, are described. C...
Get full text
Article -
8
The role of modern antithrombotic agents in cardiovascular disease prevention
Published 1970-01-01Subjects: Get full textAtherosclerosis is one of the most urgent problems in modern cardiology. Atherosclerosis instability and coronary heart disease clinical course are based on plaque ulceration, rupture, and atherothrombosis. Atherothrombosis causes 28% of all deaths worldwide. Therefore, usage of medications targeted...
Article -
9
Hemostasis protein-coding genes, peripheral hemostasis parameters, and atherothrombosis predisposition in patients with cardiovascular disease
Published 2011-08-01Subjects: “…atherothrombosis…”Aim. To study the associations between polymorphic variants of hemostasis protein-coding genes, hemostasis system functioning, and atherothrombosis development in patients with cardiovascular disease (CVD). Material and methods. The study included 76 patients. Polymorphic gene marker alleles were an...
Get full text
Article -
10
Prevention of primary stroke in adults and children
Published 2021-06-01Subjects: Get full textModern views of stroke prevention are discussed. Universally recognized strategies of stroke prevention are analyzed and new approaches to preventive treatment of cerebral circulation disorders are proposed.
Article -
11
Acute coronary syndrome: how to reduce the residual inflammatory risk?
Published 2020-03-01Subjects: Get full textInflammatory mediators play an important role in the pathogenesis of acute coronary syndrome (ACS). The results of experimental and randomized clinical trials on the role of various inflammation inhibitors in the treatment of coronary artery disease (CAD), in particular CANTOS and COLCOT, mark a new...
Article -
12
PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE?
Published 2016-01-01Subjects: Get full textArterial hypertension (HT) is a reason for raising a question about need for antithrombotic therapy. At the same time, increased blood pressure associated with an increased risk of hemorrhagic complications. Possible ways to minimize the hemorrhagic risk in different groups of hypertensive patients...
Article -
13
Hyperlipoproteinemia(a) as a dangerous genetically determined violation of lipid metabolism and a risk factor for atherothrombosis and cardiovascular diseases
Published 2019-06-01Subjects: Get full textLipoprotein(a) (Lp(a)) is a complex supramolecular complex belonging to apoB100 lipoproteins. Lp(a) consists of a particle of similar low-density lipoprotein, in which the apolipoprotein molecule В100 is covalently linked by a disulfide bond with a unique polymorphic apolipoprotein(a) molecule. The...
Article -
14
RISK OF RECURRENT THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME AND HIGH PLASMA LEVELS OF D-DIMER
Published 2013-08-01Subjects: Get full textAim. To study the association of plasma D-dimer levels and the risk of thrombotic events in patients hospitalised with acute coronary syndrome (ACS).Material and methods. The study included 70 patients, aged 34-88 years, who were admitted to the Acute Coronary Care Unit with the ACS diagnosis.Result...
Article -
15
MECHANISMS OF CARDIOVASCULAR DISEASES DEVELOPMENT IN OBESITY AND INSULIN RESISTANCE: FOCUS ON ATHEROTHROMBOSIS
Published 2016-09-01Subjects: Get full textArticle takes into consideration pathogenetic mechanisms of cardiovascular diseases development in obesity and insulin resistance, approaches to atherothrombotic complications prevention. The issues of resistance to antiplatelet drugs are condsidered and possible ways for its overcome. The data ...
Article -
16
Comparative clinical and laboratory study of rivaroxaban and its generic forms in patients with stable coronary artery disease
Published 2025-03-01Subjects: Get full textThe course and complications of coronary artery disease (CAD) are associated with atherosclerosis progression and a high probability of atherothrombosis. Antithrombotic therapy is the most effective strategy for preventing cardiovascular events in atherosclerotic diseases. In accordance with current...
Article -
17
CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES
Published 2016-01-01Subjects: Get full textAtherothrombosis is a complication of ischemic heart disease, and it leads to development of acute coronary syndrome. Atherothrombosis is characterized by sudden destruction of atherosclerotic plaque, which results into platelets activation and thrombus formation. Aspirin - one of the most widely us...
Article -
18
ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS
Published 2016-01-01Subjects: Get full textAim. To analyze the literary and own data about clopidogrel influence on platelets during inflammation and to reveal particularities of its usage in ischemic heart disease (IHD) patients with active inflammation. Material and methods. The platelet morphology and a number of leukocyte-platelet aggreg...
Article -
19
THROMBOPHILIA AND INTENSITY OF THE INTRAVASCULAR MICROCOAGULATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROTHROMBOSIS
Published 2015-09-01Subjects: Get full textAim. To study the intensity of the intravascular microcoagulation in patients with atherothrombosis (AT), chronic obstructive pulmonary disease (COPD) and thrombophilia.Material and methods. 115 patients were enrolled into the study: 37 patients with COPD (22 with thrombophilia and 15 without thromb...
Article -
20
Prognosis of patients with coronary artery disease and diabetes — what to look for
Published 2024-10-01Subjects: Get full textPatients with coronary artery disease (CAD) and diabetes are identified as a high cardiovascular risk group both in Russia and abroad. Having similar paths of development and progression of atherosclerosis and atherothrombosis, these diseases potentiate each other's thrombogenesis mechanisms. A...
Article